COX-2 expression and cell cycle progression in human fibroblasts

American Journal of Physiology - Cell Physiology

Volumn 281, Issue 1 50-1, 2001, Pages

  Gilroy, Derek W ^a,b   Saunders, Michael A ^a   Wu, Kenneth K ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Apoptosis; Cyclooxygenase 2; Interleukin 1 ; Platelet derived growth factor; Proliferation; Serum

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME INDUCTION; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

EID: 0034805383     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2001.281.1.c188     Document Type: Article

References (32)

1. 1 phase of the cell cycle by indomethacin
2. Proliferation is necessary for both repair and mutation in transgenic mouse cells
3. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells
4. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids
5. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2
6. Cyclooxygenase in biology and disease
7. Cell cycle dependent expression of cyclooxygenase-2 in human fibroblasts
8. Human cyclooxygenase-2 cDNA
9. The transcriptional program in the response of human fibroblasts to serum
10. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
11. Prostaglandin mediated modulation of transforming growth factor-β metabolism in primary mouse osteoblastic cells in vitro
12. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
13. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
14. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
15. 2
16. Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
17. A restriction point for control of normal animal cell proliferation
18. Xenobiotic metabolizing cytochrome P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde
19. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
20. An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes
21. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells
22. The effect of nonsteroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
23. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
24. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells
25. The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxydeoxyguanosine formation and stimulates apoptosis in mucosa during early colonic inflammation in rats
26. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism
27. Alterations in cellular adhesion and apoptosis in epithelial cells over-expressing prostaglandin endoperoxide synthase 2
28. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation
29. Biochemical pharmacology of nonsteroidal anti-inflammatory drugs
30. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum
31. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
32. Malignant transformation and antineoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenasenull embryo fibroblasts